Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Rebel fighter training

Training new recruits to Congo's M23 insurgent group.  Slideshow 

Photo

Venezuela's toilet paper shortage

Supplies of food and other basic products have been patchy in recent months.  Slideshow 

Sponsored Links

Ablynx books success with arthritis drug study

Related Topics

BRUSSELS | Wed Feb 13, 2013 2:03am EST

BRUSSELS (Reuters) - Belgian biotech firm Ablynx said a clinical study of its rheumatoid arthritis drug ALX-0061 showed promising results and it was now considering how to further develop the drug, including a partnership deal with a bigger company.

"We are now investigating the various possibilities through which we can progress the development of ALX-0061, including discussions with potential partners and other paths which will allow us to maximise the value of this asset," Chief Executive Edwin Moses said in a statement on Wednesday.

Ablynx had carried out the study on 37 patients over the course of 24 weeks and said the drug was well-tolerated and showed positive results.

(Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.